Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | LUNA18 |
| Synonyms | |
| Therapy Description |
LUNA18 is a cyclic peptide that inhibits Ras, potentially leading to decreased proliferation of Ras-expressing tumor cells (PMID: 36109865, NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| LUNA18 | LUNA 18|LUNA-18 | RAS Inhibitor (Pan) 13 | LUNA18 is a cyclic peptide that inhibits Ras, potentially leading to decreased proliferation of Ras-expressing tumor cells (PMID: 36109865, NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05012618 | Phase I | LUNA18 | A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). | Active, not recruiting | USA | 1 |